Aethlon Medical Inc.

NASDAQ: AEMD · Real-Time Price · USD
1.15
-0.02 (-1.71%)
At close: Aug 15, 2025, 3:59 PM
1.16
1.31%
After-hours: Aug 15, 2025, 07:12 PM EDT

Aethlon Medical Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-1.77B -13.39M -9.56M -11.27M -11.5M -12.21M -12.25M -11.63M -12.41M -12.03M -13.35M -13.03M -11.23M -10.42M -8.9M -8.82M -8.58M -7.89M -7.41M -5.79M -5.72M
Depreciation & Amortization
82.89M 339.56K 341.53K 349.19K 354.79K 359.06K 352.77K 339.42K 300.57K 240.89K 186.67K 126.22K 142.67K 123.69K 109.53K 102.59K 42.84K 39.94K 39.15K 38.66K 32.27K
Stock-Based Compensation
72.72M 415.23K 481.91K 964.9K 1.11M 1.22M 1.34M 1.03M 1.09M 1.05M 1.02M 958.38K 845.9K 750.62K 672.45K 849.39K 815.37K 779.42K 717.56K 442.18K 601.67K
Other Working Capital
-128.9K 147.05K 252.15K 802.19K 474.44K 321.98K 288.12K -36.27K 15.12K 112.1K 415.31K -76K -264.41K -386.88K -139.35K -277.71K -93.86K 97.65K -137.97K 452.49K 351.98K
Other Non-Cash Items
-103.26M 4.89M 226.39K 158.41K 18.82K 21.28K 5.65K 16.7K 159.97K 166.53K 186.32K 184.47K 39.4K 30.53K 8.95K -3.71K -3.37K -2.49K -69.61K -68.75K -22.96K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -55.59K -51.19K
Change in Working Capital
-506.04K 93.69K -29.54K 892.08K 620.28K 478.66K 39.63K 160.56K 600.18K 65.34K 1.3M 335.25K -223.69K -251.11K -797.87K -518.05K -10.84K 309.69K 578.36K 226.53K 112.22K
Operating Cash Flow
-1.72B -7.65M -8.54M -8.91M -9.39M -10.13M -10.51M -10.08M -10.26M -10.51M -10.66M -11.42M -10.42M -9.77M -8.91M -8.39M -7.73M -6.76M -6.15M -5.21M -5.05M
Capital Expenditures
n/a -3 -7.1K -13.72K -20.49K -250.87K -257.25K -399.93K -1.13M -943.11K -1.14M -1.05M -351.99K -349.19K -142.05K -115.61K -80.45K -59.88K -58.23K -54.82K -168.59K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -7.1K -13.71K -20.48K -250.87K -257.25K -399.93K -1.13M -943.11K -1.14M -1.05M -351.99K -349.19K -142.05K -115.61K -80.45K -59.88K -58.23K -54.82K -168.59K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -892.59K
Common Stock Repurchased
-10.9K -10.9K -10.9K -3.83K -9.84K -9.84K -9.84K -9.84K n/a n/a n/a -13.56K -41.69K -41.69K -41.69K -94.15K -82.14K -82.14K -82.14K -16.13K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.15M 4.2M -12.27K -21.64K -21.64K -24.93K -20.38K -12.89K -20.86K -12.49K -20.5K -32.17K -52.33K -88.12K -103.61K -156.07K -144.06K -132.53K -108.35K -49.1K -41.42K
Financial Cash Flow
-3.01M 7.73M 5.41M 5.6M 5.59M 1.29M 1.24M 1.06M 9.37M 8.91M 8.91M 8.9M 567.11K 17.37M 17.35M 17.3M 17.31M 7.13M 14.32M 18.95M 18.45M
Net Cash Flow
-1.74B 69.59K -3.15M -3.32M -3.83M -9.09M -9.53M -9.43M -2.02M -2.54M -2.89M -3.53M -10.16M 7.3M 8.35M 8.8M 9.5M 303.52K 8.12M 13.69M 13.23M
Free Cash Flow
-1.72B -7.65M -8.55M -8.92M -9.42M -10.38M -10.77M -10.48M -11.39M -11.45M -11.8M -12.48M -10.78M -10.12M -9.05M -8.5M -7.82M -6.82M -6.2M -5.26M -5.22M